Table 2.
Characteristics | Patient A | Patient B | Patient C | Patient D |
---|---|---|---|---|
Age at recurrence, y | 65 | 55 | 67 | 68 |
Time of recurrence | Second time | First time | First time | First time |
Disease-free interval, months | 42 | 15 | 14 | 7 |
Site of recurrence | Abdominal wall | Chest wall | Ilium | Paraaortic lymph node |
Pathological type of recurrent tumor | Endometrioid | Endometrioid | Endometrioid | Clear cell |
Gradea | Grade 3 | Grade 3 | Grade 3 | – |
Molecular subytpe | TP53 mutant | NSMP | NSMP | TP53 mutant |
Chemotherapy before sampling | Yes | Yes | Yes | Yes |
Radiotherapy before sampling | Yes | No | No | No |
Targeted therapy before sampling | No | No | No | No |
Grade was only determined in endometrioid EC. EC, endometrial cancer; NSMP, no specific molecular profile.